Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference in San Francisco on January 12

PALO ALTO, Calif., Jan. 5, 2011 /PRNewswire via COMTEX/ --

Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that the company will make a presentation at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 12, 2011 at 2:00 p.m. Pacific Time/ 5:00 p.m. Eastern Time. Bruce Cozadd, the company's chairman and chief executive officer, will provide a business and financial update.

A live webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

An archived version of the webcast will be available for at least one week on the Investors section of the company's website at www.jazzpharmaceuticals.com.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals (Nasdaq: JAZZ) is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information see www.jazzpharmaceuticals.com.

SOURCE Jazz Pharmaceuticals, Inc.